1. Home
  2. KOPN vs CCCC Comparison

KOPN vs CCCC Comparison

Compare KOPN & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOPN
  • CCCC
  • Stock Information
  • Founded
  • KOPN 1984
  • CCCC 2015
  • Country
  • KOPN United States
  • CCCC United States
  • Employees
  • KOPN N/A
  • CCCC N/A
  • Industry
  • KOPN Semiconductors
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOPN Technology
  • CCCC Health Care
  • Exchange
  • KOPN Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • KOPN 138.4M
  • CCCC 115.0M
  • IPO Year
  • KOPN 1992
  • CCCC 2020
  • Fundamental
  • Price
  • KOPN $1.43
  • CCCC $1.47
  • Analyst Decision
  • KOPN Strong Buy
  • CCCC Buy
  • Analyst Count
  • KOPN 4
  • CCCC 4
  • Target Price
  • KOPN $2.56
  • CCCC $12.50
  • AVG Volume (30 Days)
  • KOPN 2.2M
  • CCCC 1.3M
  • Earning Date
  • KOPN 05-16-2025
  • CCCC 05-07-2025
  • Dividend Yield
  • KOPN N/A
  • CCCC N/A
  • EPS Growth
  • KOPN N/A
  • CCCC N/A
  • EPS
  • KOPN N/A
  • CCCC N/A
  • Revenue
  • KOPN $50,335,167.00
  • CCCC $39,783,000.00
  • Revenue This Year
  • KOPN $8.75
  • CCCC N/A
  • Revenue Next Year
  • KOPN $24.15
  • CCCC $36.31
  • P/E Ratio
  • KOPN N/A
  • CCCC N/A
  • Revenue Growth
  • KOPN 24.61
  • CCCC 98.56
  • 52 Week Low
  • KOPN $0.56
  • CCCC $1.09
  • 52 Week High
  • KOPN $2.17
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • KOPN 66.87
  • CCCC 44.60
  • Support Level
  • KOPN $1.24
  • CCCC $1.42
  • Resistance Level
  • KOPN $1.38
  • CCCC $1.69
  • Average True Range (ATR)
  • KOPN 0.09
  • CCCC 0.16
  • MACD
  • KOPN 0.04
  • CCCC 0.03
  • Stochastic Oscillator
  • KOPN 98.09
  • CCCC 27.27

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: